Discover
URGN
UroGen Pharma Ltd.
37.94
2 x 28.26
2 x 48.00
bid
ask
+
1.14
3.10%
2 @ 04:00 PM
37.94 +0.00 (0.00%)
| Ytd | 62.00% | |
| 1y | 191.40% |
37.11
day range
39.59
12.73
52 week range
39.59
| Open | 37.11 | Prev Close | 36.80 | Low | 37.11 | High | 39.59 | Mkt Cap | 1.85B |
| Vol | 1.09M | Avg Vol | 799.07K | EPS | -2.74 | P/E | N/A | Forward P/E | 29.95 |
| Beta | 1.62 | Short Ratio | 9.82 | Inst. Own | 100.58% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 29.01 | 200-d Avg | 22.75 | 1yr Est | 36.88 |
URGN News
fool.com
Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Let Go of 10,000 Shares?
10,000 shares were sold for a transaction value of ~$350,000 at a weighted average price of around $
benzinga.com
HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $45 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates UroGen Pharma (NASDAQ:URGN) with a
benzinga.com
UroGen Pharma Announces Settlement And License Agreement With Teva Pharmaceuticals Relating to JELMY
This Agreement resolves the patent litigation UroGen initiated in response to Teva's submission